DAWN Other Income/Expenses (Net)

Day One Biopharmaceuticals Inc · Other Income/Expenses (Net)

DAWN logo

DAWN Other Income/Expenses (Net)

Latest reported$18.45M
DAWN TTM Other Income/Expenses (Net) (-$30.06M → $18.45M)
High-resolution chart · PNG

DAWN other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Day One Biopharmaceuticals Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
18,452,000
20,340,000
22,334,000
129,634,000
128,918,000
127,832,000
126,601,000
18,040,000
17,147,000
14,775,000
11,391,000
8,189,000
4,728,000
2,131,000
228,000
5,000
-11,000
-29,504,000
-29,786,000
-29,852,000
-30,060,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.